[Federal Register: April 6, 2001 (Volume 66, Number 67)]
[Notices]               
[Page 18305]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06ap01-79]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 3, 2000, Ansys 
Technologies, Inc., 25200 Commercentre Drive, Lake Forest, California 
92630, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471).......................  II
1-Piperidinocyclohexane carbonitrile (PCC)   II
 (8603).
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 5, 2001.

    Dated: March 29, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-8550 Filed 4-5-01; 8:45 am]
BILLING CODE 4410-09-M